Adage Capital Partners Gp, L.L.C. Takeda Pharmaceutical CO LTD Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,533,725 shares of TAK stock, worth $37.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,533,725
Previous 3,433,023
26.2%
Holding current value
$37.1 Million
Previous $51 Million
23.27%
% of portfolio
0.07%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding TAK
# of Institutions
367Shares Held
70.8MCall Options Held
3.3MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$195 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$111 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$65.8 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$58.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$54.3 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...